Substance P
Substance P (SP) is a neuropeptide - a substance that functions as a neurotransmitter and as a neuromodulator
Substance P is an important element in pain perception. The sensory function of substance P is thought to be related to the transmission of pain information into the central nervous system. Substance P coexists with the excitatory neurotransmitter glutamate in primary afferents that respond to painful stimulation.[14]
Substance P has been associated with the regulation of mood disorders, anxiety, stress,[15] reinforcement,[16] neurogenesis,[17] respiratory rhythm,[18]neurotoxicity, nausea/emesis,[19] pain and nociception.[20] Substance P and other sensory neuropeptides can be released from the peripheral terminals of sensory nerve fibers in the skin, muscle and joints. It is proposed that this release is involved in neurogenic inflammation, which is a local inflammatory response to certain types of infection or injury.[21] The regulatory function of SP also involves the regulation of its high-affinity receptor, NK-1. Substance P receptor antagonists may have important therapeutic applications in the treatment of a variety of stress-related illnesses, in addition to their potential as analgesics.
Substance P causes a "fight or flight" response, and there is evidence of substance P antagonists blocking this stress response via blockade of substance P receptors in the amygdala.
MK 869 was discovered by Merck Research Laboratories as the first nonpeptide substance P antagonist with possible human utility. the drug may possibly be effective in the treatment of other psychiatric illnesses, such as panic disorder, obsessive-compulsive disorder, generalized anxiety disorder,
Substance P is an important element in pain perception. The sensory function of substance P is thought to be related to the transmission of pain information into the central nervous system. Substance P coexists with the excitatory neurotransmitter glutamate in primary afferents that respond to painful stimulation.[14]
Substance P has been associated with the regulation of mood disorders, anxiety, stress,[15] reinforcement,[16] neurogenesis,[17] respiratory rhythm,[18]neurotoxicity, nausea/emesis,[19] pain and nociception.[20] Substance P and other sensory neuropeptides can be released from the peripheral terminals of sensory nerve fibers in the skin, muscle and joints. It is proposed that this release is involved in neurogenic inflammation, which is a local inflammatory response to certain types of infection or injury.[21] The regulatory function of SP also involves the regulation of its high-affinity receptor, NK-1. Substance P receptor antagonists may have important therapeutic applications in the treatment of a variety of stress-related illnesses, in addition to their potential as analgesics.
Substance P causes a "fight or flight" response, and there is evidence of substance P antagonists blocking this stress response via blockade of substance P receptors in the amygdala.
MK 869 was discovered by Merck Research Laboratories as the first nonpeptide substance P antagonist with possible human utility. the drug may possibly be effective in the treatment of other psychiatric illnesses, such as panic disorder, obsessive-compulsive disorder, generalized anxiety disorder,